Clarithromycin and Roxicet drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Clarithromycin (clarithromycin) and Roxicet (acetaminophen; oxycodone hydrochloride). Common drug interactions include hypersomnia among females and chronic kidney disease among males.
The phase IV clinical study analyzes what interactions people have when they take Clarithromycin and Roxicet. It is created by eHealthMe based on reports of 38 people who take the same drugs from the FDA, and is updated regularly.
What is Clarithromycin?
Clarithromycin has active ingredients of clarithromycin. It is often used in sinusitis. eHealthMe is studying from 45,044 Clarithromycin users. Check the latest studies of Clarithromycin.
What is Roxicet?
Roxicet has active ingredients of acetaminophen; oxycodone hydrochloride. It is often used in pain. eHealthMe is studying from 2,254 Roxicet users. Check the latest studies of Roxicet.
38 people who take Clarithromycin and Roxicet together, and have interactions are studied.

What are the common drug interactions of Clarithromycin and Roxicet, by gender? *:
female:
- Hypersomnia (excessive daytime sleepiness (eds))
- Intestinal polyp (small growths in the bowel with the potential for further growth)
- Malaise (a feeling of general discomfort or uneasiness)
- Back pain
- Fall
- Arthralgia (joint pain)
- Chronic kidney disease
- Nasopharyngitis (inflammation of the nasopharynx)
- Anaemia (lack of blood)
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
male:
- Chronic kidney disease
- Acute respiratory distress syndrome
- Renal failure acute (rapid kidney dysfunction)
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Renal failure (kidney dysfunction)
- Anaemia (lack of blood)
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Emotional distress
- Gait disturbance
What are the common drug interactions of Clarithromycin and Roxicet, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Chronic kidney disease
40-49:
- Acute respiratory distress syndrome
- Adverse drug reaction
- Cerebral haemorrhage (bleeding within the brain)
- Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
- Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
- Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
- Loss of consciousness
- Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
- Renal failure acute (rapid kidney dysfunction)
- Sepsis (a severe blood infection that can lead to organ failure and death)
50-59:
- Anaemia (lack of blood)
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
- Depressed mood
- Emotional distress
- Hepatic cyst
- Injury
- Metastases to bone (cancer spreads to bone)
- Osteopenia (a condition where bone mineral density is lower than normal)
- Scar
60+:
- Chronic kidney disease
- Nephrogenic anaemia (anaemia due to kidney disease)
- Renal failure (kidney dysfunction)
- Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
- Dizziness
- Diarrhoea
- Hypersomnia (excessive daytime sleepiness (eds))
- Malaise (a feeling of general discomfort or uneasiness)
- Nasopharyngitis (inflammation of the nasopharynx)
- Somnolence (a state of near-sleep, a strong desire for sleep)
What are the existing conditions these people have? *
- High Blood Pressure: 17 people, 44.74%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 14 people, 36.84%
- Urinary Tract Infection: 13 people, 34.21%
- Stress And Anxiety: 12 people, 31.58%
- Infection: 11 people, 28.95%
- Fluid Retention (an abnormal accumulation of fluid in the blood): 11 people, 28.95%
- High Blood Cholesterol: 11 people, 28.95%
- Inflammation: 8 people, 21.05%
- Swelling: 8 people, 21.05%
- Depression: 8 people, 21.05%
* Approximation only. Some reports may have incomplete information.
Do you take Clarithromycin and Roxicet?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Clarithromycin (45,044 reports)
- Roxicet (2,254 reports)
Browse all drug interactions of Clarithromycin and Roxicet:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Clarithromycin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Roxicet:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Clarithromycin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Roxicet and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on clarithromycin and acetaminophen; oxycodone hydrochloride (the active ingredients of Clarithromycin and Roxicet, respectively), and Clarithromycin and Roxicet (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Potassium Citrate and Ambrisentan - 6 seconds ago
- Drug interactions of Aciphex and Mevacor - 15 seconds ago
- Cardiac Disorder and Dyskinesia - 22 seconds ago
- Could Sudafed cause Uveitis? - 28 seconds ago
- Drug interactions of Glucovance and Zetia - 32 seconds ago
- Drug interactions of Aripiprazole and Opsumit - 35 seconds ago
- Could Mephyton cause Rash Pruritic? - 43 seconds ago
- Asthma and Abnormal Dreams - 46 seconds ago
- Drug interactions of Tramadol and Taltz - 48 seconds ago
- Drug interactions of Nicorette and Humira - 48 seconds ago